• LAST PRICE
    28.1100
  • TODAY'S CHANGE (%)
    Trending Down-0.2400 (-0.8466%)
  • Bid / Lots
    11.2400/ 2
  • Ask / Lots
    33.1000/ 10
  • Open / Previous Close
    28.4300 / 28.3500
  • Day Range
    Low 27.9450
    High 30.0700
  • 52 Week Range
    Low 19.8500
    High 57.2000
  • Volume
    416,384
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 28.35
TimeVolumeCLDX
09:32 ET238928.22
09:34 ET88228.925
09:36 ET40028.985
09:38 ET94128.56
09:39 ET30028.66
09:41 ET225328.67
09:43 ET210028.635
09:48 ET150028.63
09:50 ET30028.64
09:52 ET110028.655
09:54 ET80028.69
09:56 ET10028.82
09:57 ET69928.91
10:08 ET70028.84
10:10 ET111728.8
10:12 ET10028.83
10:14 ET60628.79
10:15 ET50028.86
10:19 ET30028.97
10:21 ET44828.96
10:26 ET20029.19
10:35 ET83329.24
10:39 ET52229.3301
10:42 ET20029.43
10:44 ET216529.46
10:46 ET81029.44
10:48 ET50029.36
10:51 ET10129.48
10:53 ET10029.47
10:55 ET233129.3
10:57 ET10029.34
11:00 ET20029.37
11:02 ET143629.415
11:06 ET80029.42
11:08 ET20029.445
11:09 ET70029.455
11:11 ET110029.47
11:13 ET10029.52
11:15 ET40029.48
11:18 ET10029.5
11:22 ET106329.58
11:24 ET10029.66
11:26 ET84329.54
11:29 ET164629.49
11:31 ET10029.5
12:12 ET80029.12
12:16 ET100029.17
12:20 ET50029.14
12:21 ET150029.19
12:23 ET20029.18
12:25 ET28729.28
12:27 ET30029.28
12:30 ET29929.26
12:32 ET20029.32
12:36 ET70029.38
12:38 ET553229.405
12:39 ET148229.48
12:41 ET105229.51
12:43 ET70029.47
12:45 ET39229.4
12:48 ET10029.37
12:52 ET90029.38
12:54 ET30029.29
12:56 ET30529.26
12:59 ET10029.15
01:03 ET109929.17
01:08 ET180029.19
01:10 ET21829.19
01:12 ET40029.21
01:15 ET12329.16
01:26 ET40029.11
01:28 ET32629.1
01:30 ET10029.14
01:33 ET10029.09
01:35 ET21429.08
01:37 ET40029.05
01:42 ET30029.01
01:46 ET71328.94
01:48 ET20028.96
01:51 ET10028.9
01:53 ET40028.9
01:55 ET104428.84
01:57 ET10028.81
02:00 ET65828.75
02:04 ET30028.69
02:06 ET30028.68
02:08 ET60028.79
02:09 ET40028.78
02:11 ET83828.845
02:13 ET50028.79
02:18 ET20028.89
02:20 ET30028.78
02:22 ET111228.76
02:24 ET50028.75
02:27 ET20028.73
02:29 ET20028.73
02:33 ET30128.67
02:36 ET20028.69
02:38 ET50028.665
02:42 ET10028.64
02:44 ET30828.59
02:45 ET20028.52
02:47 ET70028.505
02:49 ET20028.53
02:51 ET10028.53
02:56 ET80028.51
02:58 ET20028.46
03:00 ET30028.43
03:02 ET30028.5
03:03 ET20028.55
03:05 ET127728.53
03:07 ET71328.57
03:09 ET90228.485
03:12 ET20028.525
03:14 ET100028.415
03:16 ET70328.42
03:18 ET70028.4925
03:20 ET132128.53
03:21 ET91528.465
03:23 ET60028.455
03:25 ET80028.44
03:27 ET163828.36
03:30 ET251928.36
03:32 ET140028.32
03:34 ET10028.235
03:36 ET40028.25
03:38 ET170028.28
03:39 ET72728.18
03:41 ET97628.195
03:43 ET10028.2
03:45 ET189228.09
03:48 ET167528.145
03:50 ET130228.1801
03:52 ET552828.1
03:54 ET455127.9601
03:56 ET527028.045
03:57 ET432528.025
03:59 ET1243228.11
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCLDX
Celldex Therapeutics Inc
1.3B
-13.1x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.3B
-11.3x
---
United StatesSWTX
SpringWorks Therapeutics Inc
1.2B
-6.1x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
1.1B
-7.0x
---
United StatesAKRO
Akero Therapeutics Inc
1.2B
-10.8x
---
United StatesCINC
CinCor Pharma Inc
1.2B
0.0x
---
As of 2022-10-02

Company Information

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. It operates in development, manufacturing of therapeutics. Company's CDX-0159, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity. Its CDX-1140, an agonist monoclonal antibody targeted to CD40, a key activator of immune response, being studied in a Phase II study. The Company's CDX-527, a bispecific antibody that uses active anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which it initiated a Phase II study in advanced solid tumors.

Contact Information

Headquarters
53 Frontage Rd Ste 220HAMPTON, NJ, United States 08827-4034
Phone
908-200-7500
Fax
908-454-1911

Executives

Non-Executive Independent Chairman of the Board
Karen Shoos
President, Chief Executive Officer, Director
Anthony Marucci
Chief Financial Office, Senior Vice President, Secretary
Sam Martin
Executive Vice President, Chief Scientific Officer
Tibor Keler
Senior Vice President, General Counsel
Freddy Jimenez

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.3B
Revenue (TTM)
$824.0K
Shares Outstanding
46.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.40
EPS
$-2.14
Book Value
$8.98
P/E Ratio
-13.1x
Price/Sales (TTM)
1,570.6
Price/Cash Flow (TTM)
---
Operating Margin
-12,235.07%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.